Keyphrases
125I
8%
Acute Migraine Therapy
8%
Allodynia
17%
Analgesic
9%
Antinociception
18%
Antisense
10%
Arrestin
17%
Behavioral Effects
11%
Calcitonin Gene-related Peptide
12%
Chronic Migraine
46%
Chronic Morphine
14%
Cortical Spreading Depression
16%
Dysregulation
10%
Enhanced Green Fluorescent Protein (eGFP)
8%
G Protein-coupled Receptor
17%
Headache
19%
Histone Deacetylase Inhibitor (HDACi)
9%
Hyperalgesia
36%
Inflammatory Pain
9%
Knock-in Mouse Model
12%
Ligand-directed Signaling
9%
Medication Overuse Headache
14%
Migraine
83%
Migraine Therapy
9%
Migraine Triggers
11%
Molecular Mechanism
8%
Morphine
15%
Mouse Model
29%
Neural Complexity
9%
Nitric Oxide
11%
Nitroglycerin
60%
Novel Therapeutic Targets
8%
Nucleus Accumbens
14%
Opioid Antagonist
23%
Opioid Receptors
62%
Opioid-induced Hyperalgesia
33%
Opioids
12%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
14%
Post-traumatic Headache
11%
Receptor Agonist
14%
Receptor Function
17%
Receptor Internalization
10%
Receptor Trafficking
13%
SNC80
32%
Therapeutic Target
11%
Trigeminal Ganglion
27%
Trigeminal System
11%
δ Opioid Receptor
69%
δ-Opioid Receptor Agonist
14%
μ-opioid Receptor
20%
Neuroscience
Agonist
52%
Alcohol Withdrawal Syndrome
9%
Allodynia
14%
Alternative Splicing
9%
Antimigraine
6%
Auras
5%
Behavior (Neuroscience)
9%
Behavioral Effect
8%
Calcitonin
7%
Calcium Channel
7%
Central Nervous System
7%
Cerebral Cortex
5%
Circadian Rhythm
10%
Convulsant
5%
Delta Opiate Receptor
56%
Deltorphin
10%
Drug Therapy
5%
Enkephalin
5%
G Protein Coupled Receptor
17%
GABA Receptor
5%
Headache
38%
Histone Deacetylase Inhibitor
9%
Hyperalgesia
63%
Hypophysis Adenylate Cyclase Activating Polypeptide
9%
In Vitro
5%
In Vivo
27%
Internalization
16%
Iodine-125
8%
Medication Overuse
11%
Migraine
100%
Morphine
23%
Neuropeptide
5%
Nicotinic Receptor
6%
Nitric Oxide
11%
Nitroglycerin
39%
Nociception
11%
Nucleus Accumbens
14%
Periaqueductal Gray
5%
Receptor
89%
Receptor Agonists
44%
Receptor Trafficking
9%
Retina S Antigen
14%
Sensory Neuron
6%
Serotonergic
6%
Spreading Cortical Depression
15%
Striatum
5%
Trigeminal Ganglion
28%
Ventral Tegmental Area
6%
μ-Opioid Receptor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Alcohol Withdrawal Syndrome
9%
Allodynia
12%
Allyl
5%
Analgesic Agent
13%
Antinociception
6%
Behavioral Effect
5%
Brain Disease
5%
Calcium Channel
8%
Chronic Pain
6%
Delta Opiate Receptor
39%
Delta Opiate Receptor Agonist
26%
Desensitization
5%
Diseases
10%
Drug Development
5%
Drug Induced Headache
9%
G Protein Coupled Receptor
18%
Glyceryl Trinitrate
28%
Headache
15%
Headache and Facial Pain
7%
Histone Deacetylase Inhibitor
9%
Hyperalgesia
29%
Migraine
64%
Morphine
7%
Mouse Model
21%
Neuropeptide
5%
Nitric Oxide
5%
Opiate Agonist
16%
Opiate Receptor
44%
Opioid-Induced Hyperalgesia
14%
Posttraumatic Headache
12%
Receptor
34%
Receptor Agonist
10%
Retina S Antigen
18%
Sumatriptan
6%
Transformed Migraine
28%
Traumatic Brain Injury
6%
Triptan Derivative
5%
μ-Opioid Receptor
5%